(Q52890673)

9 May 2018

title

Ventilatory factors affecting inhaled nitric oxide concentrations during continuous-flow administration. (English)

1 reference

9 May 2018

author

Rafael Fernández

series ordinal

1

1 reference

9 May 2018

author name string

Artigas A

series ordinal

2

1 reference

9 May 2018

Blanch L

series ordinal

3

1 reference

9 May 2018

publication date

1 September 1996

1 reference

9 May 2018

published in

Journal of Critical Care

1 reference

9 May 2018

volume

11

1 reference

9 May 2018

issue

3

1 reference

9 May 2018

page(s)

138-143

1 reference

9 May 2018

Statistical methods for assessing agreement between two methods of clinical measurement

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Safety requirement for use of inhaled nitric oxide in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction in dogs. A practical nitric oxide delivery and monitoring system

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Hemodynamic effects and metabolic fate of inhaled nitric oxide in hypoxic piglets.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Guidelines for the safe administration of inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Nitrogen dioxide production during mechanical ventilation with nitric oxide in adults. Effects of ventilator internal volume, air versus nitrogen dilution, minute ventilation, and inspired oxygen fraction.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Continuous positive airway pressure modulates effect of inhaled nitric oxide on the ventilation-perfusion distributions in canine lung injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Inhaled nitric oxide in acute respiratory failure: dose-response curves

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Inhaled nitric oxide in acute respiratory failure in adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

Delivery and monitoring of inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0883-9441%2896%2990010-6

7 January 2021

10.1016/S0883-9441(96)90010-6

Identifiers

DOI

1 reference

9 May 2018

1 reference

9 May 2018